Navigation Links
Cleveland Clinic receives grant to study role of DNA damage in treatment-resistant prostate cancer
Date:12/18/2013

Wednesday, December 18, 2013: Cleveland Clinic, along with the National Cancer Institute, the University of Chicago and Thomas Jefferson University, are the recipients of a $600,000 Special Challenge Award from the Prostate Cancer Foundation (PCF) to investigate the role of abnormally high protein levels in prostate tumors.

The increased expression of approximately 25 proteins referred to as interferon-related DNA damage resistance signature (IRDS) correlates strongly with resistance to radiation and chemotherapy. African-American men with prostate cancer are much more likely to have the IRDS signature than Caucasian men, one potential reason for the observed differences in mortality from the disease.

"African-American men have a two-fold higher mortality rate from prostate cancer than European-Americans," said Eric Klein, M.D., Chairman, Glickman Urological & Kidney Institute at Cleveland Clinic, and principal investigator on the grant. "The goal of our research is to further investigate the biology behind the obvious aggressive behavior of prostate tumors in African-American men in the hopes of better understanding its biology and identifying new management and treatment options."

Cleveland Clinic is at the forefront of identifying and addressing health disparities through multidisciplinary clinical care, community outreach and education. In 2003, the Minority Men's Health Center, led by urologist Charles S. Modlin, M.D., MBA, was established in the Glickman Urological & Kidney Institute to address the vast number of medical conditions which disproportionately affect minority men. Approximately 750 patients visited the center this year, in addition to the more than 1,000 men who attend the annual Minority Men's Health Fair each April.

Prostate cancer tumors develop IRDS when exposed to interferons, potent antiviral proteins naturally produced by the body in response to a virus, bacteria or tumor cells. Inteferons were p
'/>"/>

Contact: Stephanie Jansky
JANSKYS@ccf.org
216-636-5869
Cleveland Clinic
Source:Eurekalert

Page: 1 2

Related medicine news :

1. FastFingerprints Expands in the Cleveland, Ohio Area
2. Clevelanders: Lighting up in a new way
3. NFL Punter Spencer Lanning of the Cleveland Browns Continues Fundraising Effort to Help Kicking For The Dream Fight Ovarian Cancer
4. Medical Experts Gather at Cleveland Clinic Lou Ruvo Center for Brain Health for Annual Silverado Medical Director Conference
5. Cleveland Treatment Center Launches Video Detailing Its Services for Drug, Alcohol Recovery
6. Explorys Selected as One of the Top 25 “Coolest Tech” Companies in Cleveland by Inside Business and Expedient
7. StartUp Health Showcases Digital Health Companies during Cleveland Clinic Medical Innovation Summit
8. Cleveland ENT, Dr. Bert Brown MD, Launches New Website
9. American Brain Tumor Association and Cleveland Clinic Conference Offers Continuing Education to Health Care Professionals
10. Cleveland Clinics preventive breast cancer vaccine development takes step forward
11. Cleveland Clinic research: Most statin-intolerant patients can eventually tolerate statins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ... 2015 , ... An article published August 19th by the LA ... through to open a pizzeria in Westchester. Mr. LaRocco was aware from opening prior ... but the current process, having already gone on for over a year, is taking ...
(Date:8/28/2015)... Church, VA (PRWEB) , ... ... ... Cybersecurity Risk Management for Medical Devices:, Understanding the FDA’s Position and Best ... Rockville, MD, http://www.fdanews.com/cybersecuritymd , This workshop, chaired by internationally renowned ...
(Date:8/28/2015)... ... 2015 , ... On May 30th, 2015, Best Drug Rehabilitation, a results-based substance ... A Mission” benefit concert in Mendon, IL. Held in the Show Barn at the ... music education programs in the underfunded local school districts of Mendon at neighboring Quincy, ...
(Date:8/28/2015)... ... August 28, 2015 , ... “ Frequentz ” was ... the latest and coolest applications on the market for iOS, Android, and Windows. Joe ... with viewers how this software allows businesses to track product movement from beginning to ...
(Date:8/28/2015)... , ... August 28, 2015 , ... Medical Solutions, one ... 2015 Best Places to Work in Healthcare by Modern Healthcare and will be ... , Now in its eighth year, the Best Places to Work in Healthcare program ...
Breaking Medicine News(10 mins):Health News:Article on Building Approval Process for LA Business Highlights the Need for a Bridge Between Businesses and City Officials, says Fire Protection Group Inc. 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 5Health News:New Video Released on "Music With A Mission" Benefit Concert Headlining Artist Cadillac Three & Best Drug Rehabilitation 2Health News:Track Product Movement from Beginning to End with Frequentz 2Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 2Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 3
... What: Georgetown,s Lombardi Comprehensive Cancer Center and Capital Breast ... of providing breast cancer screening to underserved women at ... DC. This is the second year the AVON Foundation ... Capital Breast Care Center to their dedication to breast ...
... May 1, Binax, Inc., a leading provider ... identify the causative pathogens of infectious diseases, announced that it ... to customers and potential customers of the BinaxNow(R) Influenza A ... A & B test has not been validated for detection ...
... greatly improved when doctors implemented a series of ... unit. Yale School of Medicine researchers report their ... American Journal of Obstetrics & Gynecology . ... determine if improving communication between medical staff and ...
... malignancies among older men , , FRIDAY, May 1 ... chronic kidney disease appear to have a higher risk ... Australian scientists report. , The observation -- which suggests ... cancer, but not prostate cancer -- adds to previous ...
... HAMILTON, Bermuda, May 1 Warner Chilcott Limited (Nasdaq: ... its subsidiaries and Mayne Pharma International Pty. Ltd. ("Mayne") ... and Mylan Inc. ("Mylan") in the District Court for ... U.S. Patent No. 6,958,161 (the ",161 Patent") which covers ...
... have embraced a simple and direct model of the disease ... bearing total responsibility for the spread of cancer to distant ... grew, and reproduced. The result was a seed-dominant model that ... tumor seed but neglecting the role of the soil. , ...
Cached Medicine News:Health News:Lombardi Cancer Center and the Capital Breast Care Center awarded $750,000 from the AVON Foundation 2Health News:Obstetrical unit at Yale-New Haven Hospital achieves dramatic improvement in patient safety 2Health News:Chronic Kidney Disease Raises Risk for Some Cancers 2Health News:Chronic Kidney Disease Raises Risk for Some Cancers 3Health News:Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent 2Health News:Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent 3Health News:Where tumor cells boldly go: Weill Cornell cancer biologists shed light on the metastatic niche 2
(Date:8/28/2015)... The report "Eubiotics Market by Type (Probiotics, Prebiotics, Organic Acids, ... by Region ( North America , ... of the World) - Global Trends and Forecast to 2020", ... at USD 4.62 Billion in 2014 and is projected to ... 7.4% from 2015 to 2020. Browse 77 ...
(Date:8/27/2015)... 2015  The Academy of Managed Care Pharmacy ... (FDA,s) draft guidance and proposed rule that calls ... bear a nonproprietary name with an FDA-designated suffix. ... decision from the FDA on the naming issue ... urging the agency to use the same nonproprietary ...
(Date:8/27/2015)... ieCrowd™ today announced the achievement of ... the company,s supplemental oxygen delivery device, Smart Oxygen ... by ieCrowd,s subsidiary Smart Oxygen Solutions TM , ... oxygen based on level of activity.  The FDA ... Smart Oxygen device would require a series of ...
Breaking Medicine Technology:Eubiotics Market Worth 7.05 Billion USD by 2020 2Eubiotics Market Worth 7.05 Billion USD by 2020 3Eubiotics Market Worth 7.05 Billion USD by 2020 4Eubiotics Market Worth 7.05 Billion USD by 2020 5AMCP Is Disappointed in FDA's Draft Guidance and Proposed Rule Calling for Suffix on Nonproprietary Names of Biological Products 2Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 2Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 3Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 4
... 2011 The U.S. Food and Drug Administration today approved ... patients at risk of stroke due to clogged neck arteries ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) The carotid arteries ... brain. The blood flow in the arteries can become partially ...
... May 6, 2011 On Thursday, the U.S. Food ... with progressive neuroendocrine tumors located in the pancreas (PNET) ... spread to other parts of the body (metastatic).   ... tumors found in the pancreas are slow-growing and rare. ...
Cached Medicine Technology:FDA Expands Approved Use For Carotid Stent 2FDA Expands Approved Use For Carotid Stent 3FDA Approves New Treatment for Rare Type of Pancreatic Cancer 2
Inquire...
The Perfect Vac Quad Manifold allows one to four 96-well plates to be processed simultaneously. A single plate may be processed in 30 minutes; four plates are processed in 45 minutes....
... Rotary, Vacuum-Style and Nitrogen Blow-Down Evaporators. For over ten years TurboVap concentration technology has received enormous acclaim ... ... ... ...
The Empore 96 well plate vacuum manifold comes complete with waste tray, gasket and shims, may be used as a stand-alone or with 96-well automation....
Medicine Products: